Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Medpace Holdings, Inc. | medp-ex311_9.htm |
| EX-31.2 - EX-31.2 - Medpace Holdings, Inc. | medp-ex312_8.htm |
| EX-32.2 - EX-32.2 - Medpace Holdings, Inc. | medp-ex322_6.htm |
| 10-Q - 10-Q - Medpace Holdings, Inc. | medp-10q_20210630.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Medpace Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2021 filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
• |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. |
Date: July 27, 2021
|
By: |
|
/s/ August J. Troendle |
|
|
|
August J. Troendle |
|
|
|
President, Chief Executive Officer and Chairman of the Board of Directors |
|
|
|
(Principal Executive Officer) |